Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HAAPARANTA M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 77 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
      Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    2. Nurmi, E; Ruottinen, HM; Bergman, J; Haaparanta, M; Solin, O; Sonninen, P; Rinne, JO
      Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study

      MOVEMENT DISORDERS
    3. Sutinen, E; Jyrkkio, S; Gronroos, T; Haaparanta, M; Lehikoinen, P; Nagren, K
      Biodistribution of [C-11]methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    4. Bruck, A; Portin, R; Lindell, A; Laihinen, A; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus

      NEUROSCIENCE LETTERS
    5. Gronroos, T; Eskola, I; Lehtio, K; Minn, H; Marjamaki, P; Bergman, J; Haaparanta, M; Forsback, S; Solin, O
      Pharmacokinetics of [F-18]FETNIM: A potential hypoxia marker for PET

      JOURNAL OF NUCLEAR MEDICINE
    6. Lamusuo, S; Jutila, L; Ylinen, A; Kalviainen, R; Mervaala, E; Haaparanta, M; Jaaskelainen, S; Partanen, K; Vapalahti, M; Rinne, J
      [F-18]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage

      ARCHIVES OF NEUROLOGY
    7. Nurmi, E; Ruottinen, HM; Kaasinen, V; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT

      ANNALS OF NEUROLOGY
    8. Laihinen, A; Ruottinen, H; Rinne, JO; Haaparanta, M; Bergman, J; Solin, O; Koskenvuo, M; Marttila, R; Rinne, UK
      Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET

      JOURNAL OF NEUROLOGY
    9. Ruottinen, HM; Partinen, M; Hublin, C; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

      NEUROLOGY
    10. DeJesus, OT; Haaparanta, M; Solin, O; Nickles, RJ
      6-FluoroDOPA metabolism in rat striatum: time course of extracellular metabolites

      BRAIN RESEARCH
    11. Rinne, JO; Portin, R; Ruottinen, H; Nurmi, E; Bergman, J; Haaparanta, M; Solin, O
      Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study

      ARCHIVES OF NEUROLOGY
    12. Salokangas, RKR; Vilkman, H; Ilonen, T; Taiminen, T; Bergman, J; Haaparanta, M; Solin, O; Alanen, A; Syvalahti, E; Hietala, J
      High levels of dopamine activity in the basal ganglia of cigarette smokers

      AMERICAN JOURNAL OF PSYCHIATRY
    13. Laakso, A; Vilkman, H; Alakare, B; Haaparanta, M; Bergman, J; Solin, O; Peurasaari, J; Rakkolainen, V; Syvalahti, E; Hietala, J
      Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography

      AMERICAN JOURNAL OF PSYCHIATRY
    14. Laakso, A; Vilkman, H; Kajander, J; Bergman, J; Haaparanta, M; Solin, O; Hietala, J
      Prediction of detached personality in healthy subjects by low dopamine transporter binding

      AMERICAN JOURNAL OF PSYCHIATRY
    15. Hietala, J; Syvalahti, E; Vilkman, H; Vuorio, K; Rakkolainen, V; Bergman, J; Haaparanta, M; Solin, O; Kuoppamaki, M; Eronen, E; Ruotsalainen, U; Salokangas, RKR
      Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia

      SCHIZOPHRENIA RESEARCH
    16. Rinne, JO; Bergman, J; Ruottinen, H; Haaparanta, M; Eronen, E; Oikonen, V; Sonninen, P; Solin, O
      Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease

      SYNAPSE
    17. Takala, TO; Nuutila, P; Katoh, C; Luotolahti, M; Bergman, J; Maki, M; Oikonen, V; Ruotsalainen, U; Gronroos, T; Haaparanta, M; Kapanen, S; Knuuti, J
      Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    18. Suhonen-Polvi, H; Varho, T; Metsahonkala, L; Haataja, L; Ruotsalainen, U; Haaparanta, M; Bergman, J; Solin, O; Aarimaa, T; Holopainen, I; Vainionpaa, L; Manner, T; Jaaskelainen, S; Renlund, M; Sillanpaa, M; Aula, P
      Increased brain glucose utilization in Salla disease (free sialic acid storage disorder)

      JOURNAL OF NUCLEAR MEDICINE
    19. Rinne, JO; Ruottinen, H; Bergman, J; Haaparanta, M; Sonninen, P; Solin, O
      Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    20. Turpeinen, AK; Takala, TO; Nuutila, P; Axelin, T; Luotolahti, M; Haaparanta, M; Bergman, J; Hamalainen, H; Iida, H; Maki, M; Uusitupa, MIJ; Knuuti, J
      Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance - Studies with PET and 14(R, S)-[F-18]fluoro-6-thia-heptadecanoic acid

      DIABETES
    21. Laine, H; Katoh, C; Luotolahti, M; Yki-Jarvinen, H; Kantola, I; Jula, A; Takala, TO; Ruotsalainen, U; Iida, H; Haaparanta, M; Nuutila, P; Knuuti, J
      Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy

      CIRCULATION
    22. Nuutinen, J; Minn, H; Bergman, J; Haaparanta, M; Ruotsalainen, U; Laine, H; Knuuti, J
      Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study

      BRITISH JOURNAL OF CANCER
    23. LAAKSO A; BERGMAN J; HAAPARANTA M; VILKMAN H; SOLIN O; HIETALA J
      [F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS

      Synapse
    24. LAAKSO A; VILKMAN H; ALAKARE B; HAAPARANTA M; BERGMAN J; SOLIN O; PEURASAARI J; RAKKOLAINEN V; SYVALAHTI EKG; HIETALA J
      ABNORMAL ASYMMETRY OF DOPAMINERGIC NERVE-TERMINALS IN THE CAUDATE-NUCLEUS OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS

      Nordic journal of psychiatry
    25. LAINE H; KNUUTI MJ; RUOTSALAINEN U; RAITAKARI M; IIDA H; KAPANEN J; KIRVELA O; HAAPARANTA M; YKIJARVINEN H; NUUTILA P
      INSULIN-RESISTANCE IN ESSENTIAL-HYPERTENSION IS CHARACTERIZED BY IMPAIRED INSULIN STIMULATION OF BLOOD-FLOW IN SKELETAL-MUSCLE

      Journal of hypertension
    26. MAKI MT; HAAPARANTA M; NUUTILA P; OIKONEN V; LUOTOLAHTI M; ESKOLA O; KNUUTI JM
      FREE FATTY-ACID UPTAKE IN THE MYOCARDIUM AND SKELETAL-MUSCLE USING FLUORINE-18-FLUORO-6-THIA-HEPTADECANOIC ACID

      The Journal of nuclear medicine
    27. LAINE M; YKIJARVINEN H; KIRVELA O; TOLVANEN T; RAITAKARI M; SOLIN O; HAAPARANTA M; KNUUTI J; NUUTILA P
      INSULIN-RESISTANCE OF GLUCOSE-UPTAKE IN SKELETAL-MUSCLE CANNOT BE AMELIORATED BY ENHANCING ENDOTHELIUM-DEPENDENT BLOOD-FLOW IN OBESITY

      The Journal of clinical investigation
    28. UTRIAINEN T; TAKALA T; LUOTOLAHTI M; RONNEMAA T; LAINE H; RUOTSALAINEN U; HAAPARANTA M; NUUTILA P; YKIJARVINEN H
      INSULIN-RESISTANCE CHARACTERIZES GLUCOSE-UPTAKE IN SKELETAL-MUSCLE BUT NOT IN THE HEART IN NIDDM

      Diabetologia
    29. TURPEINEN AK; TAKALA TO; NUUTILA P; LUOTOLAHTI M; HAAPARANTA M; BERGMAN J; HAMALAINEN H; UUSITUPA MIJ; KNUUTI J
      CARDIAC AND FEMORAL MUSCLE FFA UPTAKE IN PATIENTS WITH IGT OR NIDDM AS STUDIED WITH 14(R,S)-[18F]FLUORO-6-THIA-HEPTADECANOIC ACID AND PET

      Diabetologia
    30. KINNALA A; NUUTILA P; RUOTSALAINEN U; TERAS M; BERGMAN J; HAAPARANTA M; SOLIN O; KORVENRANTA H; AARIMAA T; WEGELIUS U; KERO P; SUHONENPOLVI H
      CEREBRAL METABOLIC-RATE FOR GLUCOSE AFTER NEONATAL HYPOGLYCEMIA

      Early human development
    31. MINN H; LAPELA M; KLEMI PJ; GRENMAN R; LESKINEN S; LINDHOLM P; BERGMAN J; ERONEN E; HAAPARANTA M; JOENSUU H
      PREDICTION OF SURVIVAL WITH FLUORINE-18-FLUORODEOXYGLUCOSE AND PET INHEAD AND NECK-CANCER

      The Journal of nuclear medicine
    32. MALMINIEMI K; LAINE H; KNUUTI MJ; RUOTSALAINEN U; OIKONEN V; HAAPARANTA M; NUUTILA P
      ACUTE EFFECTS OF CELIPROLOL ON MUSCLE BLOOD-FLOW AND INSULIN SENSITIVITY - STUDIES USING [O-15]-WATER, [F-18] FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY

      European Journal of Clinical Pharmacology
    33. LAMUSUO S; RUOTTINEN HM; KNUUTI J; HARKONEN R; RUOTSALAINEN U; BERGMAN J; HAAPARANTA M; SOLIN O; MERVAALA E; NOUSIAINEN U; JAASKELAINEN S; YLINEN A; KALVIAINEN R; RINNE JK; VAPALAHTI M; RINNE JO
      COMPARISON OF [F-18] FDG-PET, [TC-99M]-HMPAO-SPECT, AND [I-123] IOMAZENIL-SPECT IN LOCALIZING THE EPILEPTOGENIC CORTEX

      Journal of Neurology, Neurosurgery and Psychiatry
    34. RUOTTINEN HM; RINNE JO; HAAPARANTA M; SOLIN O; BERGMAN J; OIKONEN VJ; JARVELA I; SANTAVUORI P
      [F-18] FLUORODOPA PET SHOWS STRIATAL DOPAMINERGIC DYSFUNCTION IN JUVENILE NEURONAL CEROID-LIPOFUSCINOSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    35. UTRIAINEN T; NUUTILA P; TAKALA T; VICINI P; RUOTSALAINEN U; RONNEMAA T; TOLVANEN T; RAITAKARI M; HAAPARANTA M; KIRVELA O; COBELLI C; YKIJARVINEN H
      INTACT INSULIN STIMULATION OF SKELETAL-MUSCLE BLOOD-FLOW, ITS HETEROGENEITY AND REDISTRIBUTION, BUT NOT OF GLUCOSE-UPTAKE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      The Journal of clinical investigation
    36. TAKALA TO; NUUTILA P; LUOTOLAHTI M; HAAPARANTA M; BERGMAN J; MAKI M; KNUUTI J
      EFFECTS OF ENDURANCE TRAINING ON MYOCARDIAL AND SKELETAL-MUSCLE FATTY-ACID BETA-OXIDATION

      Diabetologia
    37. PAUL R; HAAPARANTA M; BERGMAN J; KAMARAINEN EL; SOLIN O
      IN-VIVO MICRODIALYSIS WITH 2-(F-18)FLUORO-2-DEOXY-D-GLUCOSE FOR STUDYING GLUCOSE-METABOLISM - A NEW METHOD

      Diabetologia
    38. MAKI M; NUUTILA P; LAINE H; VOIPIOPULKKI LM; HAAPARANTA M; SOLIN O; KNUUTI JM
      MYOCARDIAL GLUCOSE-UPTAKE IN PATIENTS WITH NIDDM AND STABLE CORONARY-ARTERY DISEASE

      Diabetes
    39. HAAPARANTA M; BERGMAN J; LAAKSO A; HIETALA J; SOLIN O
      [F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS

      Synapse
    40. SOLIN O; ENAS JD; BERGMAN J; HAAPARANTA M; VANBROCKLIN HF; BUDINGER TF
      SYNTHESIS OF [F-18] FLUOROATIPAMEZOLE - BIODISTRIBUTION IN RATS

      The Journal of nuclear medicine
    41. NUUTINEN J; LESKINEN S; ELOMAA I; SALMINEN E; HAAPARANTA M; RUOTSALAINEN U; WEGELIUS U; MINN H; JOENSUU H
      FDG-PET IMAGING OF RESIDUAL TESTICULAR CANCER AFTER CHEMOTHERAPY

      The Journal of nuclear medicine
    42. RUOTSALAINEN U; SUHONENPOLVI H; ERONEN E; KINNALA A; BERGMAN J; HAAPARANTA M; TERAS M; SOLIN O; WEGELIUS U
      ESTIMATED RADIATION-DOSE TO THE NEWBORN IN FDG-PET STUDIES

      The Journal of nuclear medicine
    43. RAITAKARI M; NUUTILA P; RUOTSALAINEN U; LAINE H; TERAS M; IIDA H; MAKIMATTILA S; UTRIAINEN T; OIKONEN V; SIPILA H; HAAPARANTA M; SOLIN O; WEGELIUS U; KNUUTI J; YKIJARVINEN H
      EVIDENCE FOR DISSOCIATION OF INSULIN STIMULATION OF BLOOD-FLOW AND GLUCOSE-UPTAKE IN HUMAN SKELETAL-MUSCLE - STUDIES USING [O-15]H2O, [F-18] FLUORO-2-DEOXY-D-GLUCOSE, AND POSITRON EMISSION TOMOGRAPHY

      Diabetes
    44. MAKI M; LUOTOLAHTI M; NUUTILA P; IIDA H; VOIPIOPULKKI LM; RUOTSALAINEN U; HAAPARANTA M; SOLIN O; HARTIALA J; HARKONEN R; KNUUTI J
      GLUCOSE-UPTAKE IN THE CHRONICALLY DYSFUNCTIONAL BUT VIABLE MYOCARDIUM

      Circulation
    45. KINNALA A; SUHONENPOLVI H; AARIMAA T; KERO P; KORVENRANTA H; RUOTSALAINEN U; BERGMAN J; HAAPARANTA M; SOLIN O; NUUTILA P; WEGELIUS U
      CEREBRAL METABOLIC-RATE FOR GLUCOSE DURING THE FIRST 6 MONTHS OF LIFE- AN FDG POSITRON EMISSION TOMOGRAPHY STUDY

      Archives of Disease in Childhood
    46. SUHONENPOLVI H; SALMI TT; KORHONEN T; NORVASUOHEILA MK; RUOTSALAINEN U; RIIKONEN R; BERGMAN J; HAAPARANTA M; NUUTILA P; VALAVAARA R; SONNINEN P; WEGELIUS U
      CEREBRAL GLUCOSE-UTILIZATION MEASURED WITH POSITRON EMISSION TOMOGRAPHY (PET) AS AN INDEX FOR NEUROLOGICAL FUNCTIONING IN LONG-TERM SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

      International journal of pediatric hematology/oncology
    47. HAAPARANTA M; PAUL R; HUOVINEN R; KUJARI H; BERGMAN J; SOLIN O; KANGAS L
      PHARMACOKINETICS AND METABOLISM OF 2-[F-18]FLUORO-2-DEOXY-D-GLUCOSE (FDG) IN MAMMARY-TUMORS OF ANTIESTROGEN-TREATED RATS

      Nuclear medicine and biology
    48. BERGMAN J; JOHNSTROM P; HAAPARANTA M; SOLIN O; DUELFER T; STONEELANDER S
      RADIOLABELING OF 2-OXOQUAZEPAM WITH ELECTROPHILIC F-18 PREPARED FROM [F-18] FLUORIDE

      Applied radiation and isotopes
    49. LAPELA M; LESKINEN S; MINN H; LINDHOLM P; KLEMI P; SODERSTROM KO; HAAPARANTA M; JOENSUU H; NORDMAN E
      INCREASED GLUCOSE-METABOLISM IN NON-HODGKINS-LYMPHOMA AS STUDIED WITHFDG PET

      European journal of cancer
    50. SUHONENPOLVI H; RUOTSALAINEN U; KINNALA A; BERGMAN J; HAAPARANTA M; TERAS M; MAKELA P; SOLIN O; WEGELIUS U
      FDG-PET IN EARLY INFANCY - SIMPLIFIED QUANTIFICATION METHODS TO MEASURE CEREBRAL GLUCOSE-UTILIZATION

      The Journal of nuclear medicine
    51. HIETALA J; SYVALAHTI E; VUORIO K; RAKKOLAINEN V; BERGMAN J; HAAPARANTA M; SOLIN O; KUOPPAMAKI M; KIRVELA O; RUOTSALAINEN U; SALOKANGAS RKR
      PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS

      Lancet
    52. LAPELA M; GRENMAN R; KURKI T; JOENSUU H; LESKINEN S; LINDHOLM P; HAAPARANTA M; RUOTSALAINEN U; MINN H
      HEAD AND NECK-CANCER - DETECTION OF RECURRENCE WITH PET AND 2-[F-18]FLUORO-2-DEOXY-D-GLUCOSE

      Radiology
    53. KNUUTI MJ; MAKI M; YKIJARVINEN H; VOIPIOPULKKI LM; HARKONEN R; HAAPARANTA M; NUUTILA P
      THE EFFECT OF INSULIN AND FFA ON MYOCARDIAL GLUCOSE-UPTAKE

      Journal of Molecular and Cellular Cardiology
    54. NUUTILA P; MAKI M; LAINE H; KNUUTI MJ; RUOTSALAINEN U; LUOTOLAHTI M; HAAPARANTA M; SOLIN O; JULA A; KOIVISTO VA; VOIPIOPULKKI LM; YKIJARVINEN H
      INSULIN ACTION ON HEART AND SKELETAL-MUSCLE GLUCOSE-UPTAKE IN ESSENTIAL-HYPERTENSION

      The Journal of clinical investigation
    55. LAMUSUO S; FORSS N; HAAPARANTA M; HARI R; MERVAALA E; MAKELA JP; RINNE JO; RUOTSALAINEN U; VALPALAHTI M
      FDG-PET AND WHOLE-SCALP MAGNETOENCEPHALOGRAPHY IN THE LOCALIZATION OFEPILEPTOGENIC CORTEX

      Epilepsia
    56. NUUTILA P; LAINE H; RAITAKARI M; KIRVELA O; RUOTSALAINEN U; SIPILA H; TERAS M; HAAPARANTA M; YKIJARVINEN H
      EFFECT OF BRADYKININ ON FEMORAL MUSCLE BLOOD-FLOW AND GLUCOSE-UPTAKE IN NORMAL SUBJECTS

      Diabetologia
    57. NUUTILA P; KNUUTI MJ; MAKI M; LAINE H; RUOTSALAINEN U; TERAS M; HAAPARANTA M; SOLIN O; YKIJARVINEN H
      GENDER AND INSULIN SENSITIVITY IN THE HEART AND IN SKELETAL-MUSCLES -STUDIES USING POSITRON EMISSION TOMOGRAPHY

      Diabetes
    58. NUUTILA P; RAITAKARI M; LAINE H; RUOTSALAINEN U; KIRVELA O; KNUUTI J; TERAS M; SIPILA H; HAAPARANTA M; YKIJARVINEN H
      INSULIN SENSITIVITY OF GLUCOSE-UPTAKE, BLOOD-FLOW AND VOLUME IN IDDM AS MEASURED WITH (FDG)-F-18, (H2O)-O-15 AND (CO)-O-15 AND POSITRON EMISSION TOMOGRAPHY (PET)

      Diabetes
    59. LAPELA M; LESKINEN S; MINN HRI; LINDHOLM P; KLEMI PJ; SODERSTROM KO; BERGMAN J; HAAPARANTA M; RUOTSALAINEN U; SOLIN O; JOENSUU H
      INCREASED GLUCOSE-METABOLISM IN UNTREATED NON-HODGKINS-LYMPHOMA - A STUDY WITH POSITRON EMISSION TOMOGRAPHY AND FLUORINE-18-FLUORODEOXYGLUCOSE

      Blood
    60. NUUTILA P; KNUUTI MJ; RAITAKARI M; RUOTSALAINEN U; TERAS M; VOIPIOPULKKI LM; HAAPARANTA M; SOLIN O; WEGELIUS U; YKIJARVINEN H
      EFFECT OF ANTILIPOLYSIS ON HEART AND SKELETAL-MUSCLE GLUCOSE-UPTAKE IN OVERNIGHT FASTED HUMANS

      American journal of physiology: endocrinology and metabolism
    61. KNUUTI MJ; YKIJARVINEN H; VOIPIOPULKKI LM; MAKI M; RUOTSALAINEN U; HARKONEN R; TERAS M; HAAPARANTA M; BERGMAN J; HARTIALA J; WEGELIUS U; NUUTILA P
      ENHANCEMENT OF MYOCARDIAL [FLUORINE-18]FLUORODEOXYGLUCOSE UPTAKE BY ANICOTINIC-ACID DERIVATIVE

      The Journal of nuclear medicine
    62. BERGMAN J; HAAPARANTA M; KAMARAINEN EL; PAUL R; SOLIN O
      MICRODIALYSIS FOR IN-VIVO STUDIES OF GLUCOSE-METABOLISM IN RATS USING2-(F-18)FDG

      The Journal of nuclear medicine
    63. NUUTILA P; MAKI M; RAITAKARI M; KNUUTI MJ; RUOTSALAINEN U; HAAPARANTA M; VOIPIOPULKKI LM; WEGELIUS U; YKIJARVINEN H
      DOSE-RESPONSE CHARACTERISTICS FOR INSULIN ACTION IN HEART AND SKELETAL-MUSCLES

      Diabetologia
    64. NUUTILA P; RUOTSALAINEN U; SIPILA H; TERAS M; HAAPARANTA M; KNUUTI J; YKIJARVINEN H
      SIMULTANEOUS QUANTITATION OF INSULIN-INDUCED INCREASES IN GLUCOSE-UPTAKE AND BLOOD-FLOW IN SKELETAL-MUSCLE USING O-15-WATER, 18FDG AND PET

      Diabetes
    65. KNUUTI MJ; SARASTE M; NUUTILA P; HARKONEN R; WEGELIUS U; HAAPANEN A; BERGMAN J; HAAPARANTA M; SAVUNEN T; VOIPIOPULKKI LM
      MYOCARDIAL VIABILITY - FLUORINE-18-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN PREDICTION OF WALL-MOTION RECOVERY AFTER REVASCULARIZATION

      The American heart journal
    66. BLOMQVIST G; SEITZ RJ; SJOGREN I; HALLDIN C; STONEELANDER S; WIDEN L; SOLIN O; HAAPARANTA M
      REGIONAL CEREBRAL OXIDATIVE AND TOTAL GLUCOSE CONSUMPTION DURING RESTAND ACTIVATION STUDIED WITH POSITRON EMISSION TOMOGRAPHY

      Acta Physiologica Scandinavica
    67. SUHONENPOLVI H; KERO P; KORVENRANTA H; RUOTSALAINEN U; HAAPARANTA M; BERGMAN J; SIMELL O; WEGELIUS U
      REPEATED FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY OF THE BRAININ INFANTS WITH SUSPECTED HYPOXIC-ISCHEMIC BRAIN INJURY

      European journal of nuclear medicine
    68. KNUUTI MJ; NUUTILA P; RUOTSALAINEN U; TERAS M; SARASTE M; HARKONEN R; AHONEN A; WEGELIUS U; HAAPANEN A; BERGMAN J; HAAPARANTA M; VOIPIOPULKKI LM
      QUANTITATIVE-ANALYSIS OF GLUCOSE-UTILIZATION BY 18-FDG PET IN DETECTING MYOCARDIAL VIABILITY

      The Journal of nuclear medicine
    69. LINDHOLM P; LESKINENKALLIO S; MINN H; BERGMAN J; HAAPARANTA M; LEHIKOINEN P; NAGREN K; RUOTSALAINEN U; TERAS M; JOENSUU H; WEGELIUS U; NORDMAN E
      UPTAKE OF 18F-FLUORODEOXYGLUCOSE AND 11C-METHIONINE IN HEAD AND NECK-CANCER

      The Journal of nuclear medicine
    70. KNUUTI MJ; YKIJARVINEN H; VOIPIOPULKKI LM; WEGELIUS U; TERAS M; RUOTSALAINEN U; HARKONEN R; HAAPARANTA M; NUUTILA P
      ENHANCEMENT OF MYOCARDIAL GLUCOSE-UTILIZATION BY ACIPIMOX - A NEW METHOD FOR 18-FDG PET IMAGING

      The Journal of nuclear medicine
    71. VOIPIOPULKKI LM; NUUTILA P; KNUUTI MJ; RUOTSALAINEN U; HAAPARANTA M; TERAS M; WEGELIUS U; KOIVISTO VA
      HEART AND SKELETAL-MUSCLE GLUCOSE DISPOSAL IN TYPE-2 DIABETIC-PATIENTS AS DETERMINED BY POSITRON EMISSION TOMOGRAPHY

      The Journal of nuclear medicine
    72. KNUUTI MJ; NUUTILA P; RUOTSALAINEN U; TERAS M; SARASTE M; HARKONEN R; AHONEN A; WEGELIUS U; HAAPANEN A; BERGMAN J; HAAPARANTA M; VOIPIOPULKKI LM
      THE VALUE OF QUANTITATIVE-ANALYSIS OF GLUCOSE-UTILIZATION IN DETECTION OF MYOCARDIAL VIABILITY BY PET

      The Journal of nuclear medicine
    73. LINDHOLM P; LESKINENKALLIO S; MINN H; BERGMAN J; HAAPARANTA M; LEHIKOINEN P; NAGREN K; RUOTSALAINEN U; TERAS M; JOENSUU H
      COMPARISON OF FLUORINE-18-FLUORODEOXYGLUCOSE AND CARBON-11-METHIONINEIN HEAD AND NECK-CANCER

      The Journal of nuclear medicine
    74. KOIVISTO VA; HEINONEN O; KNUUTI MJ; RUOTSALAINEN U; TERAS M; YKIJARVINEN H; HAAPARANTA M; BERGMAN J; VOIPIOPULKKI LM; WEGELIUS U; NUUTILA P
      HEART INSULIN SENSITIVITY IS DECREASED IN ELITE-CLASS ATHLETES

      Diabetologia
    75. NUUTILA P; KNUUTI MJ; RUOTSALAINEN U; TERAS M; VOIPIOPULKKI LM; HAAPARANTA M; BERGMAN J; YKIJARVINEN H
      DIFFERENCES IN THE REGULATION OF GLUCOSE-UPTAKE BY FREE FATTY-ACIDS IN HEART AND SKELETAL-MUSCLE IN MAN

      Diabetologia
    76. NUUTILA P; KNUUTI J; RUOTSALAINEN U; HEINONEN O; HAAPARANTA M; VOIPIOPULKKI LM; WEGELIUS U; KOIVISTO VA
      PHYSICAL-TRAINING DECREASES HEART INSULIN SENSITIVITY

      Diabetes
    77. NUUTILA P; KNUUTI J; RUOTSALAINEN U; KOIVISTO VA; ERONEN E; TERAS M; BERGMAN J; HAAPARANTA M; VOIPIOPULKKI LM; VIIKARI J; RONNEMAA T; WEGELIUS U; YKIJARVINEN H
      INSULIN RESISTANCE IS LOCALIZED TO SKELETAL BUT NOT HEART-MUSCLE IN TYPE-1 DIABETES

      The American journal of physiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 03:57:15